发明名称 Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor for the Prevention of Neutropenia
摘要 Disclosed are compositions and methods for treating, preventing and ameliorating conditions and diseases characterized by a lowered white blood cell count. The methods and compositions described herein include a fusion polypeptide formed from human serum albumin protein (“HSA”) and human granulocyte-colony stimulating factor (“G-CSF”).
申请公布号 US2015202268(A1) 申请公布日期 2015.07.23
申请号 US201414574553 申请日期 2014.12.18
申请人 TEVA PHARMACEUTICAL INDUSTRIES LTD. 发明人 BOCK Jason Benjamin;BELL Adam Carr;HERPST Jeffery
分类号 A61K38/38;A61K38/19 主分类号 A61K38/38
代理机构 代理人
主权项 1. A method of treating or preventing neutropenia in a human subject comprising administering to a human subject exhibiting neutropenia or at risk of developing neutropenia, recombinant human albumin-human granulocyte colony stimulating factor in an amount effective to treat the subject.
地址 Petach Tikva IL